Latest Articles
Team angelMD • May 3, 2019

Each of the following companies joined AngelMD during the month of April, 2019. Make sure to follow the companies that are operating within your areas of interest in order to stay up to date with their progress. Artificial Intelligence Theseus AI Bio Science Animatus BioScience Frontier Bio Medical Device Spark Biomedical Swede Support Glenhurst Labs ...
Read more

LinkedInTwitterFacebook
Michael Raymer • May 2, 2019

Three main drivers for macro-economic growth for any country’s economy include accumulation/deployment of capital, increase in labor outputs, and technology advancement. AngelMD is focused on driving healthcare growth by both unlocking access to capital and supporting the very best healthcare technology advancements. Family offices today are playing an increasing role in deployment of capital on ...
Read more

LinkedInTwitterFacebook
Michael Raymer • April 25, 2019

Amazon is the disruptive threat that is considered by many healthcare corporate strategists during their annual planning cycle. Amazon is a threat because they have a demonstrable track record of wringing out the inefficiencies in markets. The acquisition of Whole Foods terrified the traditional grocery chains — and the market agreed driving down their stock ...
Read more

LinkedInTwitterFacebook
Team angelMD • April 24, 2019

Congratulations are in order for AngelMD portfolio company Artoss, Inc. Artoss is a medical device company that has developed NanoBone, an advanced synthetic bone graft technology. NanoBone was tested alone (without addition of autograft or bone marrow aspirate) in the ASTM International standardized animal model and found to be equivalent to the “gold standard” autograft ...
Read more

LinkedInTwitterFacebook